In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike ProteinImmunology Published on 2022-01-102022-11-01 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2021.782506 PMC 바로가기 [Article Type] Immunology
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation patternCOVID-19 mRNA 백신에 의해 유도된 항-SARS-CoV-2 항체는 독특한 글리코실화 패턴을 나타냅니다Article Published on 2021-12-142022-09-12 Journal: Cell Reports [Category] [DOI] 10.1016/j.celrep.2021.110114 PMC 바로가기 [Article Type] Article
Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System누에-배큘로바이러스 발현 시스템을 이용한 SARS-CoV-2에 대한 CR3022 항체의 scFv, Fab 및 IgG 생산Article Published on 2021-12-012022-09-11 Journal: Molecular biotechnology [Category] [DOI] 10.1007/s12033-021-00373-0 PMC 바로가기 [Article Type] Article
Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor인간 ACE2 수용체보다 SARS-COV-2에 대한 실질적으로 더 나은 예측 결합 친화력을 갖는 FAB CC12.3의 계산 재 설계Article Published on 2021-11-122022-09-01 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-021-00684-x PMC 바로가기 [Article Type] Article
A highly potent antibody effective against SARS-CoV-2 variants of concern우려되는 SARS-CoV-2 변이체에 효과적인 매우 강력한 항체Article Published on 2021-10-122022-09-11 Journal: Cell Reports [Category] [DOI] 10.1016/j.celrep.2021.109814 PMC 바로가기 [Article Type] Article
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy생쥐에서 SARS-CoV-2 감염의 실시간 영상은 중화 항체가 최적의 효능을 위해 Fc 기능을 필요로 함을 보여줍니다Article Published on 2021-09-142022-09-11 Journal: Immunity [Category] [DOI] 10.1016/j.immuni.2021.08.015 PMC 바로가기 [Article Type] Article
Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylacticsSARS-CoV-2에 대한 강력한 인간 중화 항체의 식별이 치료제 및 예방 개발에 미치는 영향Article Published on 2021-08-092022-09-10 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-021-25153-x PMC 바로가기 [Article Type] Article
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsResearch article Published on 2021-07-072022-10-05 Journal: Cell Reports [Category] [DOI] 10.1016/j.celrep.2021.109433 [Article Type] Research article
Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?Hypothesis Published on 2021-06-132022-10-28 Journal: Pathogens [Category] [DOI] 10.3390/pathogens10060751 PMC 바로가기 [Article Type] Hypothesis
Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11Research Article Published on 2021-06-022022-10-28 Journal: Science Advances [Category] [DOI] 10.1126/sciadv.abf5632 PMC 바로가기 [Article Type] Research Article